Research teams across Canada are now building on homegrown innovation to expand the potential of RNA vaccines beyond ...

Marley Mansour was diagnosed in early 2023 after years of unanswered questions. The rare genetic disorder affects protein ...

Biotechnology company Moderna (NASDAQ:MRNA) missed Wall Street’s revenue expectations in Q1 CY2025, with sales falling 35.3% ...

Companies with more cash than debt can be financially resilient, but that doesn’t mean they’re all strong investments. Some lack leverage because they struggle to grow or generate consistent profits, ...

Fabrice Gritti, consultant scientist at Waters Corporation, spoke to LCGC International about the history of slalom ...

Researchers describe a concentric supraparticle system that protects and delivers RNA therapeutics for gene silencing in ...

Lawmakers in Iowa, Montana, Idaho, Texas and Kentucky introduced bills that would ban or restrict vaccines that use messenger RNA, or mRNA, technology — despite its immense potential for ...

Many leading pharma and biotechs have invested in messenger RNA (mRNA) technology to develop COVID-19 vaccines and are now exploring their potential in other disease areas (Figure 1). The success ...

The Boehringer Ingelheim Foundation is providing 600,000 Euros in funding for basic research into new approaches to the treatment of liver fibrosis and fatty liver hepatitis.

Yra1, other mRNA-binding proteins, the cap-binding proteins Cbp20 and Cbp80, and the poly(A) + RNA-binding protein Pab1 may jointly package mRNAs into an exportable configuration. After pre-mRNA ...